NCT01493115 - Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Insulin glargine HOE901

Pharmaceutical form:solution for injection Route of administration: subcutaneous

DRUG

Insulin glargine - New formulation HOE901

Pharmaceutical form:solution for injection Route of administration: subcutaneous

Trial Locations (1)

Investigational Site Number 392001, Fukuoka